Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nashan

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Oncogene|November 10, 2015
Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell deathS Saran, D D H Tran, F Ewald, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 21, 2015
Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life settingS Pischke, S Polywka, V M Proske, et al.
Transplantation Proceedings|February 1, 1989
Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantationK Wonigeit, B Nashan, R Schwinzer, et al.
Transplantation|September 26, 2001
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantationG L Bumgardner, I Hardie, R W Johnson, et al.
Clinical Transplantation|August 1, 1994
Spontaneous proliferation of peripheral blood lymphocytes as an indicator of intragraft immune activation in liver transplant patientsT Kiuchi, H Kato, S Kanaya, et al.
Transplantation|October 1, 1993
Persistence of donor lymphocytes in liver allograft recipientsH J Schlitt, H Kanehiro, G Raddatz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2007
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR StudyH Ekberg, J Grinyó, B Nashan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007H Ekberg, J Grinyo, B Nashan, et al.
Intensive Care Medicine|September 29, 1999
Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitorG Marx, B Nashan, M Cobas Meyer, et al.
Transplantation Proceedings|March 20, 1999
Can antibody prophylaxis allow sparing of other immunosuppressives?F Vincenti, J Grinyo, E Ramos, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Oncogene|November 10, 2015
Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell deathS Saran, D D H Tran, F Ewald, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 21, 2015
Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life settingS Pischke, S Polywka, V M Proske, et al.
Transplantation Proceedings|February 1, 1989
Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantationK Wonigeit, B Nashan, R Schwinzer, et al.
Transplantation|September 26, 2001
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantationG L Bumgardner, I Hardie, R W Johnson, et al.
Clinical Transplantation|August 1, 1994
Spontaneous proliferation of peripheral blood lymphocytes as an indicator of intragraft immune activation in liver transplant patientsT Kiuchi, H Kato, S Kanaya, et al.
Transplantation|October 1, 1993
Persistence of donor lymphocytes in liver allograft recipientsH J Schlitt, H Kanehiro, G Raddatz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2007
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR StudyH Ekberg, J Grinyó, B Nashan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007H Ekberg, J Grinyo, B Nashan, et al.
Intensive Care Medicine|September 29, 1999
Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitorG Marx, B Nashan, M Cobas Meyer, et al.
Transplantation Proceedings|March 20, 1999
Can antibody prophylaxis allow sparing of other immunosuppressives?F Vincenti, J Grinyo, E Ramos, et al.
Pageof 13